- call +1-201-465-4211
- email sales@mrinsights.biz
Vaccines are biological agents that helps the immune system to prepare for an infection against harmful pathogens.
Scope of the Report:
This report focuses on the Adult and Adolescent Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
With increasing prevalence of various cancer (cervical cancer) and infectious diseases (hepatitis A & B) accentuates the growth of the global adult and adolescent vaccines market. In addition, government initiatives for adult and adolescent vaccines also demands the market growth. The high cost of these vaccines might restrict the global adult and adolescent vaccines market.
North America and Europe dominates the global market for adult and adolescent vaccines due to increased awareness among people and rising prevalence of cervical cancer in these continent. Asia-Pacific holds the third position in adult and adolescent vaccines market owing to increasing prevalence of infectious diseases. The market for adult and adolescent in RoW region is at initial stage and is considered as an untapped market.
The worldwide market for Adult and Adolescent Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Merck
GlaxoSmithKline
Novartis
Pfizer
Sanofi Aventis
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Seasonal Vaccines
Travel Vaccines
Market Segment by Applications, can be divided into
Adult
Adolescent
There are 15 Chapters to deeply display the global Adult and Adolescent Vaccines market.
Chapter 1, to describe Adult and Adolescent Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Adult and Adolescent Vaccines, with sales, revenue, and price of Adult and Adolescent Vaccines, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Adult and Adolescent Vaccines, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Adult and Adolescent Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Adult and Adolescent Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Adult and Adolescent Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Seasonal Vaccines
1.2.2 Travel Vaccines
1.3 Market Analysis by Applications
1.3.1 Adult
1.3.2 Adolescent
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Business Overview
2.1.2 Adult and Adolescent Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck Adult and Adolescent Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 GlaxoSmithKline
2.2.1 Business Overview
2.2.2 Adult and Adolescent Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline Adult and Adolescent Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Adult and Adolescent Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Adult and Adolescent Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Adult and Adolescent Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Adult and Adolescent Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sanofi Aventis
2.5.1 Business Overview
2.5.2 Adult and Adolescent Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sanofi Aventis Adult and Adolescent Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Adult and Adolescent Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Adult and Adolescent Vaccines Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Adult and Adolescent Vaccines Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Adult and Adolescent Vaccines Manufacturer Market Share in 2017
3.3.2 Top 6 Adult and Adolescent Vaccines Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Adult and Adolescent Vaccines Market Analysis by Regions
4.1 Global Adult and Adolescent Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Adult and Adolescent Vaccines Sales and Market Share by Regions (2013-2018)
4.1.2 Global Adult and Adolescent Vaccines Revenue and Market Share by Regions (2013-2018)
4.2 North America Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
4.3 Europe Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
4.5 South America Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
5 North America Adult and Adolescent Vaccines by Countries
5.1 North America Adult and Adolescent Vaccines Sales, Revenue and Market Share by Countries
5.1.1 North America Adult and Adolescent Vaccines Sales and Market Share by Countries (2013-2018)
5.1.2 North America Adult and Adolescent Vaccines Revenue and Market Share by Countries (2013-2018)
5.2 United States Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
5.3 Canada Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
5.4 Mexico Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
6 Europe Adult and Adolescent Vaccines by Countries
6.1 Europe Adult and Adolescent Vaccines Sales, Revenue and Market Share by Countries
6.1.1 Europe Adult and Adolescent Vaccines Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Adult and Adolescent Vaccines Revenue and Market Share by Countries (2013-2018)
6.2 Germany Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
6.3 UK Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
6.4 France Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
6.5 Russia Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
6.6 Italy Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
7 Asia-Pacific Adult and Adolescent Vaccines by Countries
7.1 Asia-Pacific Adult and Adolescent Vaccines Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Adult and Adolescent Vaccines Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Adult and Adolescent Vaccines Revenue and Market Share by Countries (2013-2018)
7.2 China Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
7.3 Japan Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
7.4 Korea Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
7.5 India Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
8 South America Adult and Adolescent Vaccines by Countries
8.1 South America Adult and Adolescent Vaccines Sales, Revenue and Market Share by Countries
8.1.1 South America Adult and Adolescent Vaccines Sales and Market Share by Countries (2013-2018)
8.1.2 South America Adult and Adolescent Vaccines Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
8.3 Argentina Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
8.4 Colombia Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
9 Middle East and Africa Adult and Adolescent Vaccines by Countries
9.1 Middle East and Africa Adult and Adolescent Vaccines Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Adult and Adolescent Vaccines Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Adult and Adolescent Vaccines Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
9.3 UAE Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
9.4 Egypt Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
9.5 Nigeria Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
9.6 South Africa Adult and Adolescent Vaccines Sales and Growth Rate (2013-2018)
10 Global Adult and Adolescent Vaccines Market Segment by Type
10.1 Global Adult and Adolescent Vaccines Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Adult and Adolescent Vaccines Sales and Market Share by Type (2013-2018)
10.1.2 Global Adult and Adolescent Vaccines Revenue and Market Share by Type (2013-2018)
10.2 Seasonal Vaccines Sales Growth and Price
10.2.1 Global Seasonal Vaccines Sales Growth (2013-2018)
10.2.2 Global Seasonal Vaccines Price (2013-2018)
10.3 Travel Vaccines Sales Growth and Price
10.3.1 Global Travel Vaccines Sales Growth (2013-2018)
10.3.2 Global Travel Vaccines Price (2013-2018)
11 Global Adult and Adolescent Vaccines Market Segment by Application
11.1 Global Adult and Adolescent Vaccines Sales Market Share by Application (2013-2018)
11.2 Adult Sales Growth (2013-2018)
11.3 Adolescent Sales Growth (2013-2018)
12 Adult and Adolescent Vaccines Market Forecast (2018-2023)
12.1 Global Adult and Adolescent Vaccines Sales, Revenue and Growth Rate (2018-2023)
12.2 Adult and Adolescent Vaccines Market Forecast by Regions (2018-2023)
12.2.1 North America Adult and Adolescent Vaccines Market Forecast (2018-2023)
12.2.2 Europe Adult and Adolescent Vaccines Market Forecast (2018-2023)
12.2.3 Asia-Pacific Adult and Adolescent Vaccines Market Forecast (2018-2023)
12.2.4 South America Adult and Adolescent Vaccines Market Forecast (2018-2023)
12.2.5 Middle East and Africa Adult and Adolescent Vaccines Market Forecast (2018-2023)
12.3 Adult and Adolescent Vaccines Market Forecast by Type (2018-2023)
12.3.1 Global Adult and Adolescent Vaccines Sales Forecast by Type (2018-2023)
12.3.2 Global Adult and Adolescent Vaccines Market Share Forecast by Type (2018-2023)
12.4 Adult and Adolescent Vaccines Market Forecast by Application (2018-2023)
12.4.1 Global Adult and Adolescent Vaccines Sales Forecast by Application (2018-2023)
12.4.2 Global Adult and Adolescent Vaccines Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Adult and Adolescent Vaccines Picture
Table Product Specifications of Adult and Adolescent Vaccines
Figure Global Sales Market Share of Adult and Adolescent Vaccines
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
